Your browser doesn't support javascript.
loading
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054.
Li, Yiwen; Carpenito, Carmine; Wang, George; Surguladze, David; Forest, Amelie; Malabunga, Maria; Murphy, Mary; Zhang, Yiwei; Sonyi, Andreas; Chin, Darin; Burtrum, Douglas; Inigo, Ivan; Pennello, Anthony; Shen, Leyi; Malherbe, Laurent; Chen, Xinlei; Hall, Gerald; Haidar, Jaafar N; Ludwig, Dale L; Novosiadly, Ruslan D; Kalos, Michael.
Afiliación
  • Li Y; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA. yiwen.li@lilly.com.
  • Carpenito C; Eli Lilly and Company, 450 East 29th Street, New York, NY, 10016, USA. yiwen.li@lilly.com.
  • Wang G; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Surguladze D; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Forest A; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA.
  • Malabunga M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Murphy M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Zhang Y; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Sonyi A; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA.
  • Chin D; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Burtrum D; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Inigo I; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA.
  • Pennello A; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA.
  • Shen L; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA.
  • Malherbe L; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Chen X; Lilly Research Laboratories, Department of Non-Clinical Safety, Indianapolis, IN, USA.
  • Hall G; Lilly Research Laboratories, Department of Quantitative Biology, New York, NY, USA.
  • Haidar JN; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Ludwig DL; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
  • Novosiadly RD; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA.
  • Kalos M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA.
J Immunother Cancer ; 6(1): 45, 2018 06 04.
Article en En | MEDLINE | ID: mdl-29866166
ABSTRACT
Unfortunately, after publication of this article [1], it was noticed that corrections to the legends of Figs. 1 and 2 were not correctly incorporated. The correct legends can be seen below.
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos